Dexcom shares plummet more than 30% after company lowers fiscal year guidance

The Dexcom logo is seen on a smartphone screen and in the background.

Pavlo Gonchar | SOPA Images | Lightrocket | Getty Images

Shares of Dexcom tumbled more than 33% in after-hours trading Thursday after the diabetes management company reported disappointing revenue for the second quarter and offered weak guidance.

Here’s how the company did:

Earnings per share: 43 cents adjusted vs. 39 cents expected by LSEG
Revenue: $1 billion vs. $1.04 billion expected by LSEG

Dexcom’s revenue increased 15% from $871.3 million a year earlier, according to a release.

This is breaking news. Please refresh for updates.

Source

Technology

Good news keeps coming for Nvidia but not the stock. Time to buy?

January 8, 2026

Shares of Nvidia have started the new year off flat as Wall Street skeptics ignore a string of positive developments that continue to boost our confidence in the stock and inform our advice for investors with and without positions. The most recent update came early Thursday morning, when Bloomberg reported that China will indeed allow […]

Technology

This 2025 laggard is off to a strong start in 2026 — why the rally may not last

January 8, 2026

Every weekday, the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Thursday’s key moments. 1. The Nasdaq tumbled Thursday as investors moved away from tech stocks. Meanwhile, the Dow advanced, and the S & P 500 was little changed. Investors shouldn’t make any sudden […]

Technology

Musk, OpenAI lawyers trade barbs as lawsuit heads to trial

January 8, 2026

Elon Musk’s lawsuit against OpenAI will proceed to trial, further escalating his years-long feud with the company and its CEO, Sam Altman. “We appreciate the Court’s thorough and fair consideration and look forward to trial,” Musk’s lead counsel, Marc Toberoff, told CNBC’s David Faber Thursday in a statement following a hearing with U.S. District Judge […]